Open Orphan News Today

Most recent acquisition makes managing director the company’s second-largest shareholder after founder Cathal Friel

Open Orphan Plc (LON:ORPH – Get Free Report) rose 5.3% on Thursday . The company traded as high as GBX 10.38 ($0.13) and last traded at GBX 10 ($0.12). Approximately 652,639 shares were traded during trading, a decline of 58% from the average daily volume of 1,559,247 shares. The stock had previously closed at GBX […]

Investegate announcements from Directorate Changes

Company says it will begin paying annual dividends

IPO is fifth put together by Irish serial entrepreneur Cathal Friel in past dozen years

Investegate announcements from Proposed Appointment of Non-Executive Director

Businessman Cathal Friel has become executive chairman of Poolbeg Pharma, the same job he had at Open Orphan (now hVivo) as that firm was developed.

LONDON, UK / ACCESSWIRE / February 15, 2024 / Poolbeg Pharma (AIM:POLB, OTCQB:POLBF, "Poolbeg" or the "Company"), a biopharmaceutical company focussed on the development and commercialisation of innovative medicines targeting diseases with a high unmet medical need, announces a change of Board ro...

Poolbeg Pharma (LON:POLB, OTCQB: POLBF) announces a change in Board role and the approval of an Employee Performance Incentive Plan to align objectives and encourage retention. Cathal Friel becomes Executive Chairman, bringing valuable experience from his successful track record in public companies. The plan aims to reward and retain key senior management for sustainable growth.

New and existing institutional investors indicated demand for shares was in excess of those available